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Desmin-related myopathyBackground: αB-crystallin, once thought to be a lenticular protein, is ubiquitous and has critical roles in several
cellular processes that aremodulated by phosphorylation. Serine residues 19, 45 and 59 ofαB-crystallin undergo
phosphorylation. Phosphorylation of S45 is mediated by p44/42 MAP kinase, whereas S59 phosphorylation is
mediated by MAPKAP kinase-2. Pathway involved in S19 phosphorylation is not known.
Scope of review: The review highlights the role of phosphorylation in (i) oligomeric structure, stability and
chaperone activity, (ii) cellular processes such as apoptosis, myogenic differentiation, cell cycle regulation and
angiogenesis, and (iii) aging, stress, cardiomyopathy-causing αB-crystallin mutants, and in other diseases.
Major conclusions: Depending on the context and extent of phosphorylation, αB-crystallin seems to confer beneﬁ-
cial or deleterious effects. Phosphorylation alters structure, stability, size distribution anddynamics of the oligomeric
assembly, thus modulating chaperone activity and various cellular processes. Phosphorylated αB-crystallin has a
tendency to partition to the cytoskeleton and hence to the insoluble fraction. Low levels of phosphorylation appear
to be protective, while hyperphosphorylation has negative implications. Mutations inαB-crystallin, such as R120G,
Q151X and 464delCT, associated with inherited myoﬁbrillar myopathy lead to hyperphosphorylation and intracel-
lular inclusions. An ongoing study in our laboratory with phosphorylation-mimicking mutants indicates that phos-
phorylation of R120GαB-crystallin increases its propensity to aggregate.
General signiﬁcance: Phosphorylation of αB-crystallin has dual role that manifests either beneﬁcial or deleterious
consequences depending on the extent of phosphorylation and interaction with cytoskeleton. Considering that
disease-causingmutants ofαB-crystallin are hyperphosphorylated, moderation of phosphorylationmay be a useful
strategy in disease management. This article is part of a Special Issue entitled Crystallin Biochemistry in Health and
Disease.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction: αB-crystallin
αB-crystallin, over the last two decades, gained prominence due to
its association with multiple cellular functions. In addition to its well
studied “chaperone-like” activity in preventing aggregation of several
proteins, it has been shown to play a role in a variety of cellular func-
tions such as cell cycle, differentiation, apoptosis, gene expression and
associatedwith several disease conditions. Manifestation of such amul-
tiplicity of functions requires structural and/or functional regulation,
induced by post translational events. Several years ago we have
shown that a structural perturbation induced at about heat shock tem-
peratures, leads to signiﬁcant increase its activity. This phenomenon, in
subsequent studies, was observed with a few other small heat shocklin Biochemistry in Health and
lecular Biology (CCMB), Uppal
. This is an open access article underproteins. Phosphorylation, yet another post-translational event, appears
to play a signiﬁcant role in modulating structure and function of αB-
crystallin. Charge repulsions, due to phosphorylation of oligomeric pro-
teins, can lead to alterations in quaternary structure and consequently,
interacting surfaces and interacting partners. We focus on the phos-
phorylation of αB-crystallin in relation to its oligomeric structural
change, role in cellular functions, aging, stress and diseases.
αB-crystallin, a ubiquitous sHsp [1–3], has a highly conserved stretch
that adopts a β-sandwich, immunoglobulin-like fold called the “α-
crystallin domain (ACD)”, which is a characteristic “hallmark” of the
sHsp family [4–6]. The ACD is ﬂanked by the less conserved and ﬂexible
N-terminal domain (NTD) and the C-terminal extension (CTE) that is
rich in charged residues and includes a semi-conserved “IXI/V” motif
[4–6].αB-crystallin is particularly abundant in the eye lens alongwith an-
other sHsp,αA-crystallin, and is important for the formation of highly re-
fractive lens andmaintenance of its transparency [see reviews [7& 8]. It is
also present at high levels in cardiac and skeletalmuscles [3,9–11], where
it localizes to the sarcomeric region [11] and protects cardiomyocytes
from ischemic stress [12]. Immunostaining and subcellular fractionationthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and Z lines of the myoﬁbrils upon ischemia [13]. It exhibits ATP-
independent molecular chaperone property in preventing aggregation
of proteins [14, reviews 15–17]. It exhibits pleotropic roles in several
cellular processes such as protein folding, protein degradation, differen-
tiation and apoptosis [see reviews 17–19]. It is also found in extracellu-
lar ﬂuids [20,21], possibly through exosome-mediated secretion [22,
23], and exhibits anti-inﬂammatory property [24–28]. It seems to
have several cellular and extracellular target proteins [27, review 29].
Themechanism(s) of the pleotropic functions and promiscuous interac-
tions of sHsps in general, and αB-crystallin in particular, has not
yet been completely understood. We earlier proposed “dynamic
partitioning” hypothesis for the same [17]. αB-crystallin has three
phosphorylation sites (S19, S45 & S59) at its NTD which seem to play
a critical role in its functions. As emerging from the following sections,
phosphorylation of αB-crystallin has both beneﬁcial and deleterious
outcomes. Thus, spatio-temporally controlling phosphoryaltion of αB-
crystallin might emerge as a strategy to manage stress and age-related
complications.2. Phosphorylation of αB-crystallin
Earlier studies on phosphorylation ofαB-crystallin dealtwithmainly
rat and bovine lenses. For example, treating rat eye lenswithH2O2 stim-
ulates the phosphorylation ofαB-crystallin [30]. Phosphorylation ofαB-
crystallin in cultured bovine articular chondrocytes is induced by
phorbol 12-myristate 13-acetate, a potent tumor promoter which acti-
vates protein kinase C [31]. αB-crystallin phosphorylated at S19 or 21,
S45 and S59 residues has been found in bovine eye lens [32–34].
cAMP-dependent phosphorylation ofαB-crystallin from bovine lens ex-
tract has been reported [35,36]. Eye lens α-crystallin, composed of αA-
and αB-crystallin subunits, is believed to be phosphorylated on serine
residues by cAMP-dependent and cAMP-independent mechanisms
(see review [37]). The cAMP-independent pathway was believed to be
an autophosphorylation that has been demonstrated in vitro [37]. Dis-
aggregation of αA-, but not αB-crystallin, into tetramers results in an
appreciable increase in autophosphorylation activity [37]. It was sug-
gested that cAMP-dependent phosphorylation occurs preferentially to
αB-crystallin than αA-crystallin [37]. αB-crystallin exhibits autokinase
activity in vitro [38].
Serine residues at 19, 45, and 59 ofαB-crystallin are phosphorylated
upon exposure of human glioma (U373 MG) cells to various stimuli
such as heat, arsenite, phorbol 12-myristate 13-acetate, okadaic acid,
H2O2, anisomycin, and high concentrations of NaCl or sorbitol [39].
The study also indicated that cascade of events involving p38 MAP
kinase and p44 MAP kinase are responsible for the phosphorylation
of αB-crystallin [39]. Unlike in the case of αB-crystallin from bovine
lens extracts [35,36], the activators of cAMP-dependent protein
kinase such as forskolin, cholera toxin, and dibutyryl cAMP, did not
stimulate the phosphorylation of αB-crystallin signiﬁcantly in U373
MG cells [39].
Phosphorylation at S45 of αB-crystallin is enhanced during mito-
sis of cells and its presence is also detected in the tissue sections of
mouse embryos [40]. Phosphorylation at each site in αB-crystallin
is regulated differently/differentially during mitosis [40]. Increased
levels of S45 and S19 phosphorylation of αB-crystallin, but de-
creased levels of S59 phosphorylation, compared to control cells,
have been found in the extracts of cells from the mitotic phase [40].
Puriﬁed mitogen-activated protein kinase, p44/42 MAP kinase selec-
tively phosphorylates S45 while the substrate of the p38MAP kinase,
mitogen-activated protein kinase-activated protein-2 (MAPKAP
kinase-2) selectively phosphorylates S59 of αB-crystallin [40]. The
kinase responsible for S19 phosphorylation of αB-crystallin is yet
to be identiﬁed.2.1. Phosphorylation of αB-crystallin upon aging, stress and diseases
Phosphorylation of αB-crystallin is generally found to be elevated
upon aging, stress or diseases. Investigations on the role of αB-
crystallin (and Hsp27) and their phosphorylation status in muscle
wasting either due to disuse of muscle or aging show that the levels of
αB-crystallin andHsp27 are increased both in themuscles of aged com-
pared to young patients and in disused muscles [41,42]. The levels of
αB-crystallin phosphorylated at S59 and to some extent at S45 are in-
creased in the insoluble fraction in aged muscles as well as in disused
muscles [42,43], along with enhanced levels of phosphorylated p38
and p44/42 MAP kinases [43]. Increased phosphorylated αB-crystallin
was also observed in aged or cataractous eye lens [44,45].
Heat stress increases not only the expression level of αB-crystallin
but also its phosphorylation and increases its level in the insoluble frac-
tion [46]. Treating cells with certain drugs/reagents that can disrupt the
cytoskeleton [47], cause oxidative stress [48] or inhibit the proteosomal
machinery [49] also lead to increased phosphorylation of αB-crystallin
and accumulation in the insoluble fraction. For example, inhibition of
proteasomal activity by MG-132 in U373 MG cells leads to activation
of p38 and p44/42 MAP kinases, increased phosphorylation of αB-
crystallin (and Hsp27), and localization in aggresomes [49]. Oxidative
stress is shown to increase the phosphorylation ofαB-crystallin, leading
to co-localization with tubulin [48]. Heat stress elevates the expression
of αB-crystallin in cultured hippocampal neurons [50]. While the non-
phosphorylated forms of αB-crystallin (and Hsp25) were found in the
perikaryon and nucleus, the S19 and S45 phosphorylated forms of αB-
crystallin localized to axons and dendrites, the S59 phosphorylated
form localized to the dendrites along the plasma membrane [51].
Accumulation of αB-crystallin in the Rosenthal ﬁbers that consist of
granular deposits associated with intermediate ﬁlaments occurs in the
brains of Alexander disease patients [52–54]. Phosphorylated αB-
crystallin (at S59 and S45) was found predominantly in the insoluble
fraction of brain homogenates of Alexander and Alzheimer disease
patients [55]. Increased levels of phosphorylated αB-crystallin (S45
&S59) were also found in the brain tissue of Down syndrome people
[56]. The expression of αB-crystallin is increased in brain samples
from Alzheimer's disease and correlates with phosphorylated tau and
neuroﬁlaments [57]. Increased expression of αB-crystallin and its S59
phosphorylated form in a sub-population of glial cells with or without
the deposition of hyperphosphorylated tauhas been observed in several
tauopathies such as Alzheimer's, Pick's disease, corticobasal degenera-
tion, and argyrophilic grain disease, and phosphorylation of αB-
crystallin appears to be a protective factor [58].
Thus, during aging, stress and disease conditions, the expression
of αB-crystallin is not only elevated but its phosphorylation is also
enhanced and is represented in the insoluble fractions in many
instances.
3. Phosphorylation destabilizes αB-crystallin, increases dynamics of
subunit exchange and alters the distribution of the oligomeric
populations
Most of the studies addressing the effect of phosphorylation on the
structure and dynamics of αB-crystallin use phosphorylation-mimicking
mutants where the phosphorylable serine residues are replaced with ei-
ther aspartate or glutamate to impart negative charges. A study from
our laboratory has shown that the pseudo-phosphorylation mimic (3D-
αB-crystallin or S19D/S45D/S59D-αB-crystallin) exhibits decreased
mean hydrodynamic radius (6.4 nm) compared to that of αB-crystallin
(8.0 nm) and is more susceptible to urea-induced denaturation [59]
(Fig. 1). Various biophysical studies have shown that themean oligomeric
size of the pseudo-phosphorylationmimics ofαB-crystallin is lower than
that of the wild-typeαB-crystallin [59–61].αB-crystallin phosphorylated
in vitro using puriﬁed MAPKAP kinase 2 also showed a tendency to form
lower oligomeric species compared to wild type αB-crystallin [61].
Fig. 1.Phosphorylationmimic ofαB-crystallin exhibits altereddistribution of ensembles, populating lower oligomeric species and decreased stability. (A) Altereddistribution of phosphor-
ylation mimic (3E, i.e., S19E/S45E/S59E mutant) towards lower sedimentation coefﬁcients compared to that of the wild type (WT) αB-crystallin shown by Peschek et al. [61].
(B) 3Dimensional reconstructed model of 3E αB-oligomers (24-,12-,6-mer) observed in cryo-EM which could be superimposable with the corresponding oligomers of the docked
pseudoatomic models proposed by Braun et al. [67], indicating the hierarchical assembly principle of the wild type αB-crystallin oligomers is preserved in the phosphomimic 3E-αB-
crystallin shown by Peschek et al. [61]. Decreased stability of phosphorylation mimic (3D-αB-crystallin which exhibits decreased mean hydrodynamic radius of ~6.4 nm) towards
urea-induced unfolding compared to the wild type αB-crystallin (exhibiting mean hydrodynamic radius of ~8.0 nm) shown by a study from our laboratory (Ahmad et al. [59]) by mon-
itoring intrinsic tryptophan ﬂuorescence (C) and bis-ANS binding (D). Figures shown in panels A & B are adapted from Peschek et al. [61] with permission from PNAS, USA. Figures shown
in panels C & D are adapted from Ahmad et al. [59] with permission from Elsevier (through RightsLink).
169R. Bakthisaran et al. / Biochimica et Biophysica Acta 1860 (2016) 167–182The rapid subunit exchange process (rate constants in range of
min−1) is a unique feature of polydisperse vertebrate sHsps as well as
monodisperse plant sHsps in contrast to a very slow subunit exchange
rate (in the range of day−1) of other representativemultimeric proteins
such as tetrameric transthyretin or hepatitis B capsid protein [see re-
view 62]. Subunit exchange studies have shown that the pseudo-
phosphorylation mimics of αB-crystallin exhibit signiﬁcantly higher
rate of subunit exchange than the wild type αB-crystallin [59,61].
Thus, αB-crystallin, through its inherent subunit exchange process, ex-
ists in a spectrum of inter-converting oligomeric ensembles, and phos-
phorylation increases the rate of conversion among the spectrum of
oligomeric species with preponderance to the lower oligomers. Though
the rapid subunit exchange process among the oligomers of αB-
crystallin would limit the precise determination of the molecular mass
by various techniques used under equilibrium conditions [63], it is evi-
dent that phosphorylation or its mimicking mutations have a tendency
to alter the distribution of the oligomers towards lower oligomeric pop-
ulations. In addition to various biophysical methods such as gel-
ﬁltration and sedimentation velocity measurements, a recent cryo-EM
imaging study reveals the preponderance of lower oligomeric popula-
tions (6-mer and 12-mers) in the pseudo-phosphorylation mimic of
αB-crystallin [61]; see Fig. 1. From the 3-dimensional-reconstructed
cryo-EM images of αB-crystallin and its phosphorylation mimics, it
was observed that while the symmetric 24-mer constitutes ∼42% ofthe αB-crystallin ensemble, it constitutes only ∼6% of the pseudo-
phosphorylation mimic (3E-αB-crystallin) [61]. The species (6- and
12-mers) present at low abundance in αB-crystallin, contribute up to
∼65% of the ensembles of 3E-αB-crystallin [61].
The reconstructedmodels of the cryo-EM images also show that the
pseudo-phosphorylation mimics retain the gross structural features of
αB-crystallin as described below. Though no high resolution oligomeric
structure of full-length αB-crystallin (as well as other mammalian
sHsps) is available as yet, there is a considerable advancement in the
understanding of the structural aspects of αB-crystallin in recent
years. Studies involving analytical ultra centrifugation, small angle X-
ray scattering, NMR, negative-stained TEM, cryo-EM from different lab-
oratories show that the oligomerization of αB-crystallin follows hierar-
chical interactions involving the ACD, the CTE and the NTD in the
assembly of subunits with dimer as the stable building block [64–67].
ACD of αB-crystallin shows β-sheet-rich immunoglobulin-like fold
which can assemble as dimer [64,68–70]. The ACD forms the primary
inter-subunit interaction surfaces through anti-parallel pair-wise inter-
actions between extended β6–β7 strand from the two subunits [64,69,
70]. A hexameric unit is formed by three dimers through the conserved
IXI motif from the C-terminus of one dimer binding to hydrophobic
pockets formed by the β4 and β8 strands on the edge of another
dimer [65–67]. Interactions involving the NTD form higher-order
multimers [65–67]. Four triangular hexamers arrangedwith tetrahedral
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actions of dimeric building blocks with the existing openings in the
shell of the 24-mer make further higher-order multimeric assembly
[66]. Similarly, models of polydispersed species ofαB-crystallin ranging
from12-mer to 48-mer including the oddnumberedmultimeric species
of 23-mer are also formed [67].
However, the models of oligomeric assembly proposed by different
studies [66,67] differ with respect to ﬁner details of accommodating
the N-terminus. Both the models of a 24mer assembly show the C-
termini facing towards the surface as well as towards the inner cavity
(see [66,67] for details). However, the N-terminal region is arranged in-
ward to the central cavity in the model proposed by Jehle et al. [66],
while it is arranged towards the surface in the model proposed by
Braun et al. [67]. While the aspect with respect to spatial organization
of the N-terminal region within the oligomeric assembly is still to be
clearly understood, the proximity of the N-terminal regions from differ-
ent subunits due to the oligomeric assembly is experimentally demon-
strated. The cysteine mutants of αB-crystallin at the phosphorylable
serine residues (19, 45 &59) could form disulﬁde cross-links [61].
Charge repulsion upon phosphorylation (at the NTD), thus, would
have destabilizing effects on the oligomeric assembly of αB-crystallin
[61,67] and therefore could shift the mean populations of αB-
crystallin to hexamer and 12-mer in phosphorylation-mimicking mu-
tants. The 3-dimensional-reconstruction of the cryo-EM images of the
phosphorylation-mimicking mutant of αB-crystallin has been shown
to retain the gross structural features of the hexameric assembly of
thewild type protein [61] (Fig. 1B). Mass spectrometric studies have in-
dicated that phosphorylation could disrupt dimeric substructure within
the polydispersed oligomeric assembly of αB-crystallin [71].
Thus, phosphorylation of αB-crystallin has destabilizing effect, shifts
the distribution of oligomeric species towards lower assemblies (fewer
subunits) and increases the dynamic property of subunit exchange. As
discussed in our earlier study [59], phosphorylation-induced destabiliza-
tion of structure and assembly could be a general phenomenon by
which phosphorylation-mediated functional regulations are achieved
by the cellular system. Other examples of this effect include
(i) phosphorylation-induced destabilization as a regulatory mechanism
of the DNA-binding helix of the leucine zipper-type transcription factors
such as Fos and Jun. [72], (ii) phosphorylation of histone 1 causing de-
stabilization of chromatin structure [73] and (iii) phosphorylation of
microtubule-associated proteins leading to destabilization of microtu-
bule assembly [74]. It also appears that phosphorylation-induced desta-
bilization can promote protein/peptide aggregation. For example,
phosphorylation at a single serine residue of Trp-cage miniproteinTable 1
Modulation of the chaperone activity of αB-crystallin upon phosphorylation-mimicking mutat
Phosphorylation mimicking mutation in
αB-crystallin
Assay model
S19D/S45D/S59D Heat-induced aggregation of lac
S19D/S45D/S59D Refolding of luciferase
S19D, S45D, S59D, S45D/S59D and S19D/S45D/S59D Binding of destabilized T4 lysoz
S19D, S19D/S45D, S19D/S45D/S59D Heat induced aggregation of β-c
S19D, S19D/S45D, S19D/S45D/S59D Fibril formation of ccβ-Trp
S19D/S45D/S59D Fibril formation of RCMκ-casein
S19D/S45D/S59D DTT-induced aggregation of insu
S19D/S45D/S59D Heat-induced aggregation of cit
S19D/S45D/S59D SDS-induced amyloid ﬁbril form
S19E,S45E,S59D,
S19E/S45E,
S19E/S59E,
S45E/S59E
S19E/S45E/S59E
Heat-induced aggregation of ma
S19E,S45E,S59D,
S19E/S45E,
S19E/S59E,
S45E/S59E
S19E/S45E/S59E
Heat-induced aggregation of p5destabilizes the native fold and the resultant highly dynamic structures
form amyloid-like ordered aggregateswith high intermolecularβ-sheet
formation [75]. Interestingly, our preliminary investigation (described
in Section 9) indicates that phosphorylation-mimicking mutation of
the myopathy-causing R120GαB-crystallin promotes its aggregation.
4. Phosphorylation modulates the function of αB-crystallin
Either as homo-oligomers or as hetero-oligomerswithαA-crystallin
(as isolated from the eye lens),αB-crystallin exhibitsmolecular chaper-
one activity in preventing amorphous as well as ordered ﬁbrillar aggre-
gation of a variety of target proteins (see reviews [15–17]). It also helps
in refolding some enzymes either alone or along with other with ATP-
dependent molecular chaperones by various mechanisms (see reviews
[15–17]). In order to understand the role of phosphorylation in themo-
lecular chaperone function of αB-crystallin, various phosphorylation-
mimicking mutants have been studied.
with many target protein aggregation systems as described in
Table 1. There seems to be both decreased and increased chaperone ac-
tivities of the phosphorylation-mimicking mutants compared to wild
type αB-crystallin with respect to different targets tested.
Varied results have also been reported on the chaperone activity of
phosphorylated form(s) of αB-crystallin. Eye lens α-crystallin (com-
posed of both αA- and αB-crystallin) binds to intermediate ﬁlaments
and plays a role in its assembly [78]. The isolated forms of both the
unphosphorylated and phosphorylated forms of αB-crystallin from bo-
vine lens were reported to be equally effective in preventing in vitro as-
sembly of glial ﬁbrillary acidic protein (GFAP) and vimentin in an ATP-
independent manner [78]. They also increase the soluble pool of these
proteins upon incubation with the preformed ﬁlaments [78]. Another
study has reported that the isolated mono-phosphorylated αB-
crystallin exhibits ~30% less chaperone activity compared to the
unphosphorylated form towards heat-induced aggregation of β-
crystallin [79]. These results should be takenwith caution as the isolated
forms of unphosphorylated and phosphorylated αB-crystallin were
treated with denaturants during the isolation procedure; these isolated
forms may or may not be identical to the respective native proteins.
However, human αB-crystallin phosphorylated in vitro has been
shown to exhibit increased chaperone activity against heat-induced ag-
gregation of malate dehydrogenase and p53 [61].
The varied results reported on the effect of phosphorylation of αB-
crystallin on its chaperone activity can be considered as contradictory.
However, it is possible that these variationsmight indeed indicatemod-
ulation of the activity upon phosphorylation, depending on the targetions.
Temperature
(°C)
Chaperone activity with
respect to αB-crystallin
Reference
tate dehydrogenase 50 Decreased [60]
30 Decreased [60]
yme mutants 23 and 37 Increased [76]
rystallin and catalase 60 Increased [77]
37 Decreased [77]
37 Increased [77]
lin 25 to 45 Increased [59]
rate synthase 43 Increased [59]
ation of α-synuclein 25,37 &43 Increased [59]
late dehydrogenase 45 Increased [61]
3 42 Increased [61]
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tivity of phosphorylation-mimickingmutants of αB-crystallin increases
in relatively more number of cases, indicating that phosphorylation, in
general, has an augmentative effect. It is interesting to note that at the
target protein to chaperone ratio used in the study, wild type αB-
crystallin did not prevent the aggregation of p53 at 42 °C [61]. However,
at the same target protein to chaperone ratio, 3EαB-crystallin complete-
ly prevented the aggregation of p53 [61]. As described in our earlier
study [80], though αB-crystallin is a general chaperone and prevents
the aggregation of a variety of target proteins tested, its efﬁciency in
terms of ratio at which it can prevent the aggregation completely varies
with the target proteins. The factors that could be involved in the ob-
served target-protein-dependent efﬁciency may include the nature of
the intermediates/destabilized states, the kinetics of their formation
and the avidity of the interaction between the chaperone and the
aggregation-prone species. It has been observed that two types/modes
of interactions are involved in the molecular chaperone activities of
sHsps and the relative involvement may depend on the nature of the
intermediates of the target protein [76,80]. Given the in vivo scenario
where multiple clients exist for αB-crystallin, the relative target-
protein-dependent chaperone efﬁciency of αB-crystallin may give rise
to apparent target protein discrimination upon phosphorylation in
some cases — i.e., decreased interactions with some clients and
increased interactions with other clients leading to different physiolog-
ical consequences. Target protein discrimination effect upon phosphor-
ylation has been demonstrated for another sHsp, Hsp27 [see reviews 29,
81]. Thus, phosphorylation of αB-crystallin (and probably other sHsps)
may have both augmentative and apparent target-discriminatory
effects.
5. “Dynamic partitioning”: apparent target discrimination effect of
phosphorylation of αB-crystallin
Considering a large number of clients/targets known so far for αB-
crystallin (and Hsp27) [29] and different target protein interacting
sites spanningNTD, ACD andCTEofαB-crystallin dependingon the sub-
strates [70,82–88], the mechanism by which sHsps, including αB-
crystallin, function in vivo appears to involve pseudo-speciﬁc/broad
speciﬁc interactions (see review [17]). Therefore, we have proposed
recently a “Dynamic partitioning” hypothesis to understand the ob-
served pleotropic functions and promiscuous interactions of sHsps
(for details see review [17]). Brieﬂy, the dynamic ensembles of sHsp
species dynamically partition to substratesmediated by two types of in-
teractions. Type 1 interaction with various targets depends on the na-
ture of their equilibrium species populated among native or native-
like species to early unfolding intermediates and is reversible/transient.
Some pseudo-speciﬁc regions (for example, IPV motif of Bag 3 interacts
with the β4–β8 groove of ACD of αB-crystallin/Hsp20 [89]) on the tar-
gets become temporally accessible to sHsps (determined by phosphor-
ylation of targets, stress conditions or loss or gain of interaction with
other partners of complexes). This leads to distribution of populations
of reversible complexes. This distribution (dynamic fractional popula-
tions) of reversible complexes is subject to temporal variations due to
stimuli that can cause alteration in both number and accessibility of
interacting sites on the target proteins. Binding-induced stabilization
or steric constraints upon their interactionwith sHsps would determine
the apparent selectivity towards target proteins exhibited by sHsps in
some cases. Type I interactions help maintain cellular homeostasis
under permissible and early stress conditions, giving the cellular system
kinetic advantage to cope up with perturbations and help elicit further
protective mechanisms [17].
Type 2 interactions which are relatively stronger and less reversible
occur with aggregation-prone unfolding intermediates and/or highly
destabilized target proteins or assemblies. Temperature-dependent
perturbations of sHsps (see review [17]),ﬂexibility of N- and C-terminal
regions [62,66] and the increased dynamic exchange-mediated changein the distribution of quaternary structures [61,63] would enable the
sHsps to wrap around/mask the exposed hydrophobic surfaces and sta-
bilize the complex of some target proteins. Such relatively more stable
complex formedunder conditions of stress could either be refolded, fail-
ing which it could be targeted for degradation.
By virtue of shifting the distribution of oligomeric population to-
wards lower sized particles [59–61], phosphorylation theoretically in-
creases the number of species of αB-crystallin which has potential to
mediate type 1 and/or type 2 interactions with targets. As we have
shown earlier, though 3D-αB-crystallin exhibits increased chaperone
activity compared to wild type αB-crystallin, it still exhibits
temperature-dependent increase (further) in its chaperone activity
and also exhibits relatively less stability [59]. Thus, phosphorylation, in
general, is expected to increase the capacity (augmentation) of αB-
crystallin towards both type 1 and type 2 interactions. However, in
the in vivo situation where multiple targets co-exist, the interaction of
phosphorylated species of αB-crystallin could decrease with respect to
one or a set of targets, while increasingwith respect to other/sets of tar-
gets, leading to increased partitioning effect and apparent target
discrimination.
6. Effect of phosphorylation on functions of αB-crystallin in some
cellular processes which have both beneﬁcial and deleterious
implications
αB-crystallin participates in several cellular processes such as stress-
induced apoptosis, differentiation, cell cycle and angiogenesis where
phosphorylation of αB-crystallin is indicated to play an important
role. While its protective role in stress-induced apoptosis, differentia-
tion and cell-cycle has beneﬁcial implications, its role as a pro-
angiogenic factor and in anti-apoptotic functions (depending on the
context) may have deleterious implications (especially in cancer, age-
related macular degeneration etc.).
6.1. Phosphorylation of αB-crystallin in its anti-apoptotic function: role in
stress tolerance and myogenic differentiation
αB-crystallin has been shown to prevent apoptosis induced by vari-
ous stresses including oxidative stress, drugs such as staurosporin and
doxorubicin and cytokines such as TNFα [91–99; reviews 17,90]. αB-
crystallin is known to be involved at various stages in mitochondrial-
mediated apoptotic pathway as well as in NFκB-activated up-
regulation of the anti-apoptotic protein, Bcl-2 [see reviews 17, 90]. Var-
ious stages at which αB-crystallin exhibits anti-apoptotic function in
the mitochondrial-mediated apoptotic pathway include (i) interaction
with Bax, the pro-apoptotic molecule, inhibiting its translocation into
mitochondria and the subsequent release of cytochrome c [91], (ii)
translocation of itself to mitochondria upon oxidative stress and
protecting it [98], (iii) interacting with cytochrome-c and preventing
its oxidation [98], which may prevent cytochrome-c-mediated interac-
tion of Apaf-1 with procaspase-9 to form apoptosome and (iv)
interacting with procaspase-3, preventing its maturation to active
caspase-3 [92,93,95]. The role of phosphorylation of αB-crystallin in
anti-apoptotic activity is not completely understood. However, there
are some reports indicating importance of its phosphorylation in its
anti-apoptotic function as discussed below.
Phosphorylation of αB-crystallin on serine residues 19, 45 and 59
plays an important role in preventingmethylglyoxal-induced apoptosis
in ARPE-19 retinal pigment epithelial cells [99]. Mimicking the phos-
phorylation of αB-crystallin on S59 was found to be necessary and suf-
ﬁcient to inhibit caspase-3 and to protect cardiac myocytes against
hyperosmotic or hypoxic stress [94]. However, though αB-crystallin
confers cytoprotection through its anti-apoptotic function by inhibiting
the proteolytic activation of caspase 3 during myogenic differentiation
of C2C12 myoblasts, the 3E pseudo phosphorylation mimic of αB-
crystallin (mimicking hyperphosphorylation) was reported to be
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phorylation also seems to antagonize its anti-apoptotic function— pref-
erential interaction of S59 phosphorylated αB-crystallin with anti-
apoptotic protein, Bcl-2, leads to its sequestration and hence down-
regulation of the anti-apoptotic activity of αB-crystallin [96]. Whether
this phenomenon is part of any feed-back mechanism operating in
phosphorylation-regulated anti-apoptotic function of αB-crystallin
needs investigation. A recent study showed that S59 phosphorylated
αB-crystallin binds to the mitochondrial voltage-dependent anion
channel 1 and adenine nucleotide translocater, inhibiting the release
of cytochrome c upon myocardial infarction [100].
αB-crystallin is important in muscle tissue homeostasis as the
knockout mice forαB-crystallin die prematurely with extensive muscle
wastage [101]. The level of αB-crystallin is increased (up to ~10-fold)
during muscle cells differentiation and it plays an anti-apoptotic role
during the differentiation process [93,102]. S59 phosphorylation of
αB-crystallin is also increased during the differentiation of C2C12 myo-
blasts to myotubes, as shown by a study from our laboratory [103]. αB-
crystallin inhibitsmaturation/activation of caspase-3 and -8 in response
to TNF-α treatment [92]. TNFα is an inﬂammatory cytokine produced
by immune cells andmuscle cells during development, exercise or inju-
ry [104,105]. TNFα acts as a mitogen in skeletal muscle [105,106] and is
essential for muscle tissue homeostasis [104]. TNFαmodulates the ac-
tivity of NFκB, a ubiquitous transcription factor that regulates the ex-
pression of many genes mediating pathways either related to
cytoprotection or cell death [107,108]. Expression of αB-crystallin as
well as TNFα increases in response to stress and differentiation [102,
103]. Owing to its inﬂammatory effects, TNFαmay trigger cytotoxic ef-
fects upon prolonged exposure but is required during the differentiation
process. The elevated expression ofαB-crystallin could be the balancing
protective process. In order to understand the relation between the ele-
vated expression ofαB-crystallin and TNFα, a study fromour laboratory
[97] investigated the effect of over expression of αB-crystallin in C2C12
mouse myoblasts on TNFα-induced differentiation and cell death. The
study showed that αB-crystallin promotes NFκB activation in a
phosphorylation-dependent manner and protects myoblasts against
TNFα-induced cytotoxicity [97]. αB-crystallin interacts with IKKβ and
enhances its kinase activity, which leads to phosphorylation and subse-
quent degradation of IκBα, a negative regulator of NFκB, facilitating the
nuclear translocation of the transcription factor [97]. One of the targets
of NFκB is the transcription of Bcl-2, an anti-apoptotic protein which
was found to be up-regulated, hence protecting the cells from TNFα-
induced cytotoxicity [97]. Phosphorylation of αB-crystallin at S59 resi-
due is essential for the activation of NFκB [97]. Incidentally, TNFα also
activates p38-MAP kinase [109]. The study also showed that S59 phos-
phorylation is not required for association of αB-crystallin with the
IKK complex but is essential for enhancing the kinase activity of IKKβ
[97].
6.2. Possible role of phosphorylation of αB-crystallin in cell cycle regulation
SCF E3 ubiquitin ligase, which is primarily responsible for cyclin D1
degradation, consists of the F-box protein, Fbx4, and αB-crystallin, as
the substrate adaptors [110,111]. D-type (1, 2 and 3) cyclins bind
cyclin-dependent kinases 4 or 6 (cdk4/6), which catalyze the phosphor-
ylation of Rb proteins and promote G1/S phase transition [111]. αB-
crystallin is phosphorylated at S19 and S45 during the mitotic phase
of the cell cycle [112]. The interaction of αB-crystallin with FBX4 was
found to be increased by mimicking phosphorylation of αB-crystallin
at both S19 and S45 [112]. Cyclin D1 is seen to be elevated frequently
in human cancer [111]. Inhibition of ubiquitin-dependent proteolysis
of cyclin D1 is believed to be a primary mechanism of elevated levels
of cyclin D1 in human tumors [111]. Thus, as the FBX4-αB-crystallin
complex is involved in the substrate recognition of SCF E3 ligase, phos-
phorylation of αB-crystallin, particularly at S19 and S45, might play a
critical role in tumor suppression [111].6.3. Phosphorylation of αB-crystallin and angiogenesis
Angiogenesis (neovascularisation) is an important phenomenon
that promotes tumor growth [113,114] and also responsible for com-
promised vision in retinopathy of prematurity, diabetic retinopathy
and age-related macular degeneration [115]. Angiogenesis occurs as
an adaptive response to tissue hypoxia and is dependent on the accu-
mulation of the hypoxia inducible factors (HIFs) [116]. Hypoxia in-
creases the expression of αB-crystallin in piglet heart [117] and in
retina [118]. The importance of αB-crystallin in retina during hypoxia
is evident from the ﬁnding that αB-crystallin knock-out mouse shows
accelerated retinal degeneration in chemically induced hypoxia com-
pared to the wild type mouse [119].
Proteomic analysis of the bovine capillary endothelial cells showed
elevated levels of αB-crystallin and S59 phosphorylated αB-crystallin
during tubular morphogenesis [120]. αB-crystallin facilitates angiogen-
esis by chaperoning the vascular endothelial growth factor (VEGF) [118,
121,122]. VEGF-A promotes vascular permeability and angiogenesis and
is particularly considered as a potent angiogenic stimulator in patholog-
ic neovascularisation [123]. αB-crystallin expression is associated with
distant metastases formation in head and neck squamous cell carcino-
ma patients, and siRNA-mediated knockdown of αB-crystallin results
in decrease in VEGF-A secretion and decreased cell motility [121]. αB-
crystallin is signiﬁcantly increased and colocalized with tumor vessels
in a breast cancer xenograft [122]. It has been shown that αB-
crystallin is an important chaperone of the unfolded protein response
pathway and is a key component in the activation of the intracellular
autocrine (intracrine) VEGF pathway by protecting VEGF from intracel-
lular degradation in the tumor endothelial cells [122]. Both αB-
crystallin and VEGF-A were colocalized in cytoplasm and in endoplas-
mic reticulum and their interaction was demonstrated by immuno-
precipitation experiment [118]. S59 phosphorylated αB-crystallin is
up-regulated during retinal hyperoxia and is prominently localized to
neovascular tufts [118]. The S59 phosphorylated form binds to VEGF-
A, protects it fromdegradation in the endoplasmic reticulumand results
in increased VEGF-A protein secretion [118]. All these studies provide
ample evidence that αB-crystallin, especially the S59 phosphorylated
form, is important in intracrine and autocrine VEGF signaling pathways,
involved in folding and secretion of VEGF-A aswell as protecting it from
proteolytic degradation and helps in angiogenesis.
7. Phosphorylated αB-crystallin partitions to cytoskeleton and
nucleoskeleton
As described in the earlier sections, increased levels of phosphoryla-
tion of αB-crystallin as well as their partitioning into the insoluble frac-
tion are observed upon aging and stress (also see Figs. 2 & 3). αB-
crystallin has been shown to interactwithmicrotubules,microﬁlaments
and intermediate ﬁlaments of cytoskeleton networks. Many studies
have shown increased localization of phosphorylated αB-crystallin to
the cytoskeleton. One of the early effects of stresses such as ischemia
and hyperthermia is the disruption of the cytoskeletal assembly,
which leads to cell death. Chronic perturbation of the intermediate ﬁla-
ment network or the severe disorganization of other cytoskeletal net-
works, results in the activation of p38 MAP kinase which leads to S59
phosphorylation ofαB-crystallin and its colocalizationwith cytoskeletal
elements [47]. Depending on the cytoskeletal network that is disorga-
nized, activation of kinases RhoK, PKC or PKA upstream of p38 MAP ki-
nase selectively activate it, resulting in phosphorylation ofαB-crystallin
[47].
αB-crystallin localizes to the cytoplasm in conﬂuent lens epithelial
cell cultures, and to the lamellipodia (leading edges of cell membranes)
in migrating cells [124]. This localization of αB-crystallin is S59
phosphorylation-dependent; inhibition of its phosphorylation de-
creased its localization to the lamellipodia. αB-crystallin colocalized
with the actin meshwork, β-catenin, WAVE-1, Abi-2 and Arp3,
Fig. 2.Age-dependent partitioning of phosphorylated Hsp27 (A to C) andαB-crystallin (D to F) in to insoluble fraction shown by Yamaguchi et al. [42]. The ﬁgure and the following ﬁgure
legend are reproduced fromYamaguchi et al. [42]with permission fromOxford university press (throughRightsLink). Phosphorylation states of Hsp27 andαB-crystallinwere determined
from vastus lateralis muscle samples usingWestern blot analysis with phosphorylation site antibodies against S15, S78, or S82 peptide in Hsp27 (A–C) and with phosphorylation site an-
tibodies against S19, S45, or S59 peptide inαB-crystallin (D–F) [42]. Study groups consisted of 9 young (15–38 years) and 9 aged (51–79 years) patients [42]. Data are expressed asmeans
of 6, standard error of the mean. *p, 0.01, **p, 0.001 for young versus aged patients [42].
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tion [124]. An earlier study from our laboratory addressed the interac-
tion of αB-crystallin with actin in vivo using H9C2 rat cardiomyoblastFig. 3. Phosphorylation promotes the partitioning ofαB-crystallin in to insoluble fraction and de
et al. [46]. Analysis of time-dependent changes in the soluble and insoluble fractions ofαB-cryst
ciﬁc antibodies. (C) Immunostaining and confocal imaging shows the increased co-localiz
(D) Immunostaining and confocal images of the cells transfected with non-phosphorylable α
with actin ﬁlaments either without (WO HS+ 3A-Tfd) or with (HS+3A-Tfd) heat stress,
Figures shown in panels C & D are adapted from Singh et al. [46] with permission from Else
reproduced from the original articles which are not referred to here.cell line [46].αB-crystallin,which is uniformly distributed in the cytosol,
translocates/binds to actin ﬁlaments upon heat stress [46].αB-crystallin
binding to actin ﬁlament upon mild heat stress also inhibits thestabilized actin cytoskeleton upon heat stress shown by a study from our laboratory, Singh
allin upon heat stress probed byWestern blotting using S59 (A) and S45 (B) phospho spe-
ation of αB-crystallin with actin ﬁlaments in H9C2 cardiomyocytes upon heat stress.
B-crystallin (3A or S19A/S45A/S59A-αB-crystallin) does not show signiﬁcant interaction
indicating importance of phosphorylation in partitioning into cytoskeleton elements.
vier (through RightsLink). Note: the panel-labels inside the ﬁgures (as component) are
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Time-dependent partitioning of S45- and S59-phosphorylated αB-
crystallin in to insoluble fractions during stress has been demonstrated
[46]. Thus,αB-crystallin is differentially phosphorylated at different ser-
ine residues and may inﬂuence its association with actin stress ﬁbers.
Transiently transfected H9C2 cells with an HA-tagged non-
phosphorylable mutant of αB-crystallin (3AαB-crystallin) showed
that the distribution of 3AαB-crystallin is similar to that seen for wild-
type αB-crystallin in unstressed cells. However, 3AαB-crystallin fails
to co-localize with actin stress ﬁbers upon heat stress, indicating that
phosphorylation of αB-crystallin is important for its association with
actin stress ﬁbers (see Fig. 3). Moreover, treating the cells with speciﬁc
inhibitors of the p44 (PD98059) and p38 (SB202190) MAP kinases
(which are involved in the phosphorylation of the S45 and S59 residues,
respectively) almost completely inhibits the association ofαB-crystallin
with actin stress ﬁbers. Thus, the study [46] showed that the association
ofαB-crystallin with actin ﬁlaments is phosphorylation-dependent and
phosphorylation of both S45 and S59 is involved in the association.
However, an earlier in vitro study reported that phosphorylated bovine
eye lens αB-crystallin has comparable or slightly decreased interaction
with actin [124]. αB-crystallin or its phosphorylated forms increase
the rate of actin polymerization, and prevent the heat-induced aggrega-
tion of ﬁlamentous actin in vitro [125].αB-crystallin also inhibits the cy-
tochalasin D-induced depolymerization of actin ﬁlaments, whereas
phosphorylated αB-crystallin exhibits marked decrease in such an ac-
tivity in vitro [125]. However, it may be noted that the phosphorylated
forms ofαA- andαB-crystallin used in the in vitro study were obtained
by refolding from 6 M urea. αB-crystallin has also been shown to affect
microtubule assembly and prevent heat-induced aggregation of tubulin
[126]. αB-crystallin can interact with tubulin subunits to regulate the
equilibrium between tubulin and microtubules [127]. Low molar ratios
of αB-crystallin: tubulin were found to be favorable, while high molar
ratioswere found to be unfavorable formicrotubule assembly [127]. Re-
gions ofαB-crystallin interacting with tubulin with both increasing and
inhibiting potentials towards tubulin assembly have been reported
[128]. This suggests that the levels of interactable αB-crystallin pool
can determine the microtubule dynamics. Immunostaining and subcel-
lular fractionation showed redistribution of αB-crystallin from a cyto-
solic pool to intercalated disks and Z lines of the myoﬁbrils, with
increased fraction of phosphorylated form, upon rapid ischemia [13].
Over-expression of αB-crystallin in cardiac myocytes protects the cells
from ischemia-induced cell death and stabilizes microtubules [129].
αB-crystallin, but not Hsp27, was found to protect the microtubule in-
tegrity after simulation of ischemia [129]. S59 phosphorylated αB-
crystallin was localized at the microtubule organizing centers as well
as was co-localized with γ-tubulin in centrosomes [130].
αB-crystallin has been shown to be involved in early cellular re-
sponses of rat and porcine myocardium to ischemia [13]. Ischemia-
induced redistribution of αB-crystallin from a cytosolic pool to interca-
lated disks and Z lines of themyoﬁbrils has been shown to be accompa-
nied by its phosphorylation [13]. The time course of translocation ofαB-
crystallin to myoﬁbrils during ischemia has been found to be correlated
with phosphorylation (to the extent of ~20%) of αB-crystallin [131].
During initiation period of ischemia, αB-crystallin translocates to the
Z-line, while prolonged ischemia (irreversibly damaging) leads to ex-
treme stretching of myoﬁbrils and concomitant extension of αB-
crystallin localization from the Z-line area to I-bands [131]. During re-
perfusion after short period of ischemia (reversible ischemia), the local-
ization of αB-crystallin is reversed from Z-line, whereas upon
reperfusion after irreversibly damaging ischemia αB-crystallin remains
bound to the overstretched, damaged myoﬁbrils which are no longer
capable of contraction [131].αB-crystallin has been found to translocate
to the N(2)-line area of myoﬁbrillar I-bands of rat cardiomyocytes,
where it interacts with titin [132]. Titin extracted from ischemic pig
myocardium was shown to copurify with αB-crystallin [132]. Titin in
I-band extends as muscles are stretched. It is made up ofimmunoglobulin-like modules (having β-sheet secondary structure)
and two extensible regions (called N2B and PEVK) with no deﬁned sec-
ondary structure:αB-crystallin (recombinant protein) binds to the N2B
region of titin, but not to the PEVK region [133]. Atomic force micro-
scopic study showed that higher stretching forces were needed to un-
fold the immunoglobulin-like domains (eight-domain fragment of
titin) in the presence of αB-crystallin, indicating that αB-crystallin sta-
bilizes this domain [133]. Thus, associationwithαB-crystallin protects I-
band titin from stress liable to cause domain unfolding [133]. It is possi-
ble that compared to the unphosphorylated form, phosphorylated αB-
crystallin partitions more and/or binds strongly to the N2B region of
titin, which might contribute to the observed [131] increased, irrevers-
ible association especially with damaged myoﬁbrils (that cannot con-
tract). Increased phosphorylation of αB-crystallin at S59 and
partitioning of the phosphorylated αB-crystallin to the insoluble frac-
tions have been reported in the retina [134], heart [135] and skeletal
muscle [136] of experimentally induced diabetic rats. Phosphorylated
αB-crystallin was found to be associated with desmin of the skeletal
muscles of diabetic rats [136].
αB-crystallin (and other sHsps) binds to intermediate ﬁlaments
[137] and it has been proposed that speciﬁc combination of desmin
and R120Gmutation inαB-crystallin compromises cell viability causing
desmin-related myopathy [137]. Hyperphosphorylation of the mutant
is discussed later in Section 9. Co-localization of S59 phosphorylated
αB-crystallinwith aggregates ofmutant desmin has been observed [47].
αB-Crystallin colocalizes with the splicing factor SC35 in the nucleus
[138]. An earlier study fromour laboratory has shown thatαB-crystallin
translocates to nucleus upon heat stress with a speckled appearance,
colocalizing with the Lamin A/C nucleoskeleton assembly as well as
with SC35, probably protecting the nucleoskeleton which also harbors
the splicing machinery [139]. Phosphorylation of αB-crystallin at S59
has been shown to be important for its nuclear import through the sur-
vival motor neuron (SMN) complex [140,141]. Thus, it is likely that the
phosphorylated formofαB-crystallin imported to thenucleus partitions
to the nucleoskeleton assembly, protecting it from stress-induced
destabilization.
8. αB-crystallin in cardioprotection: dual roles of phosphorylation
The amount ofαB-crystallin in heart is as high as up to 3% of the total
protein [11]. Many studies point out the cardioprotective role of αB-
crystallin. Two aspects that emerge regarding the mechanism of
cardioprotection offered by αB-crystallin are: (i) anti-apoptotic activity
of αB-crystallin, and (ii) its binding to and stabilizing the cytoskeleton
elements. Both these aspects are interrelated to some extent. As
discussed in previous sections, phosphorylation of αB-crystallin is im-
portant for its anti-apoptotic function as well as binding or partitioning
to the cytoskeleton. However, there are reports of poor outcome upon
increased phosphorylation of αB-crystallin.
One of the causes of myocardial cell death upon ischemia and reper-
fusion is the disruption of the plasmamembrane, caused by the disinte-
gration of the plasma-membrane bound cytoskeleton and
destabilization of the plasmalemmal lipid bilayer [142,143]. A brief pe-
riod of hyperthermia has been shown to improve post-ischemic ventric-
ular recovery in rats [144,145]. Transient ischemia followed by
reperfusion is known to induce tissue damage. Though the knockout
ofαB-crystallin andHspB2 genes inmice had no effect on themyoﬁbril-
lar structure or on most of the hemodynamic properties except for
lower left ventricular end-systolic dimension, the knockout mice hearts
were found to exhibit greater apoptotic and necrotic tissue damage fol-
lowing ischemia and reperfusion compared to wild type mice hearts.
They also exhibited poorer post-ischemic contractile recovery and a sig-
niﬁcantly reduced GSH to GSSG ratio, which could be partly responsible
for the oxidative damage [146]. Transgenic over-expression of αB-
crystallin in mice has been shown to improve myocardial contractile
performance of mouse hearts subjected to 20 min ischemia followed
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genic mice were also shown to exhibit decreased oxidative stress, dis-
tinctly reduced infarct size and attenuated apoptotic cell death [147].
The level of platelet derived growth factor (PDGF-BB) increases, which
in turn induces S59phosphorylation ofαB-crystallin by p38MAP kinase
during myocardial infarction in a mouse model [148]. In mouse hearts
subjected to ex vivo ischemia, a 3-fold increase in the translocation of
S59 phosphorylated αB-crystallin to mitochondria was observed and
inhibition of S59 phosphorylation increased tissue damage and de-
creased functional recovery upon reperfusion [149]. S59 phosphorylat-
ed αB-crystallin interacts with mitochondria, thereby protecting the
myocardium at least partly by modulating the mitochondrial perme-
ability and reducing ischemia/reperfusion-induced injury [149]. As acti-
vated p38 MAP kinase translocated to the mitochondria soon after
ischemia, it was suggested that during ischemia, phosphorylation of
αB-crystallin occurred in the mitochondria at least to some extent,
where it modulates mitochondrial damage during reperfusion [150].
As mentioned earlier, phosphorylated αB-crystallin interacts with volt-
age dependent anion channel-1 and adenine nucleotide transporter
during myocardial infarction, inhibiting the release of cytochrome c
into the cytosol, thus inhibiting apoptosis [100]. αB-crystallin is
known to be up-regulated in hearts subjected to biomechanical stress
and suppress cardiac hypertrophic response [151]. The role of phos-
phorylation in its protective response to cardiac hypertrophy is not
clear.
Over-expression of αB-crystallin in transgenic mice also offers pro-
tection to heart against apoptosis and necrosis duringmyocardial ische-
mia and reperfusion [147]. Ischemia or oxidative stress can lead to the
activation of p38 and MAPKAPK-2 in the heart [152,153]. Exposure of
cardiac myocytes to sorbitol (hyperosmotic stressor) stimulated
MKK6, p38, and MAPKAP-K2 and increased S59 phosphorylation of
αB-crystallin, leading to its cytoprotective effect [154]. Blocking p38-
mediated MAPKAPK-2 activation, and thus inhibiting phosphorylation
of αB-crystallin, enhances apoptosis of myocytes [154]. Interestingly,
exogenous administration of αB-crystallin signiﬁcantly improves mu-
rine cardiac function after ischemia-reperfusion injury [155]. Cultured
cardiac myocyte cells that expressed non-phosphorylable mutant of
αB-crystallin (serine residues at 19, 45, 59 are replaced by alanine,
3AαB-crystallin), exhibited more stress-induced apoptosis compared
to control cells [94]. Cells expressing phosphorylation-mimicking mu-
tants [either S19A-S45A-S59EαB-crystallin or S19E-S45E-S59EαB-
crystallin (3EαB-crystallin)] exhibited less activation of caspase 3 and
apoptosis (3-fold) than cells expressing the non-phosphorylable mu-
tant, 3AαB-crystallin [94].
Ischemic preconditioning in rat heart increases phosphorylation
(~27%) and increased translocation ofαB-crystallin to detergent insolu-
ble fraction [156]. As mentioned earlier, during severe but brief ische-
mia in which the damage could be reversed, phosphorylated αB-
crystallin is shown to translocate from the soluble pool to themyoﬁbril-
lar Z-lines. However, in the case of severe chronic ischemia that causes
irreversible damage, phosphorylated αB-crystallin localizes to the I-
bands from the Z-lines [131]. This translocation of αB-crystallin corre-
lates with the extent of damage to cardiac myoﬁbrils during ischemia
and reperfusion [131]. Therefore, it appears that stress-induced translo-
cation ofαB-crystallin (in correlationwith its phosphorylation) to insol-
uble fraction (cytoskeleton, nucleoskeleton) would be reversible at
initial stages of stress which may provide beneﬁcial outcome, but be-
comes irreversible upon prolonged stresswhichmay lead to deleterious
outcome.
Another example where phosphorylation of αB-crystallin (and
Hsp27) may have deleterious outcome is in the procedure of
cardioplegia. Cardioplegia and cardiopulmonary bypass, increase the
phosphorylation of αB-crystallin and Hsp27, and shift them to the de-
tergent insoluble fraction, to the I-bands of the myoﬁlament in the
human myocardium [157]. αB-crystallin is phosphorylated at the S45
and S59 residues, whereas Hsp27 is phosphorylated at S15, S27 andS82 residues. The increased phosphorylation of αB-crystallin and
Hsp27 is negatively correlated with cardiac function after surgery
[157]. Inhibition of p38 MAP kinase, and thus the phosphorylation of
αB-crystallin and Hsp27, or the over-expression of non-
phosphorylable Hsp27 (all the three phosphorylable serines are re-
placed by alanines, 3A-Hsp27)were shown to signiﬁcantly improve car-
diac function after cardioplegic arrest [158]. Experiments with
myocytes that over-express 3A-Hsp27 improved contractile function
even when the phosphorylation of Hsp27 was not inhibited. These ob-
servations may be interpreted to suggest that unphosphorylated
Hsp27 is important for contractile recovery; phosphorylation per se
does not appear to affect contractile recovery, but it could deplete the
pool of unphosphorylated Hsp27 [158], thereby negatively affecting
cardiac function. While such details with respect to αB-crystallin are
not available, similar interpretation might be applicable to αB-
crystallin aswell. As discussed in a later section, the extent of phosphor-
ylation and the formation of mixed oligomers of phosphorylated forms
of these sHsps with their unphosphorylated forms or with subunits of
other sHsps may determine the outcome, either beneﬁcial or deleteri-
ous. The phosphorylated formswhich have increased partitioning to in-
soluble fractions would also take along the unphosphorylated subunits
as mixed oligomers in to the insoluble fractions.
Simulating sarcopenia by muscle disuse (rat hind limb muscles) re-
sults in increased levels of phosphorylation of αB-crystallin (and
Hsp27) and increased partitioning to the insoluble fractions which is
returned to normal level upon recovery [43]. Age-related changes and
disease/stress conditions also reﬂect increased phosphorylation and
partitioning into insoluble fraction [41,42,44,45,53–58,131]. Therefore,
it is likely that phosphorylation of αB-crystallin (also Hsp27) may dis-
play protective effect at initial stages (reversible state of phenomenon),
while its increased accumulation duringprolonged (irreversible stage of
phenomenon) stress, diseases or aging would have deleterious out-
come. The mechanism of the manifestation of the deleterious outcome
may include depletion of unphosphorylated form due to partitioning
of the mixed oligomers to the insoluble fractions (cytoskeleton or
nucleoskeleton) which may be required for other targets and/or for
the cytoskeleton/nucleoskeleton dynamics, impairment of which leads
to degeneration [159–162]. Thus, hyperphosphorylation of αB-
crystallin may have detrimental effect. There are considerable indica-
tions that hyperphosphorylation would also occur upon mutations in
αB-crystallin which lead to familial cardiomyopathy as discussed
below.
9. Hyper phosphorylation of αB-crystallin upon myoﬁbrillar
myopathy-causing mutations: the case of R120GαB-crystallin
The point mutation, R120G, inαB-crystallin leads to desmin-related
myopathy as well as congenital cataract [163]. Intracellular aggregates
containing both the mutant αB-crystallin and desmin have been ob-
served upon expressing the mutant R120GαB-crystallin in muscle cell
lines [163,164]. Even modest expression levels of R120GαB-crystallin
in a transgenicmousemodel recapitulate dominant negative phenotype
like altered desmin ﬁlaments in the cardiomyocytes, impairedmyoﬁbril
alignment and cardiac hypertrophy similar to that observed for the
desmin-related cardiomyopathies [164]. Cardiac-speciﬁc expression of
R120GαB-crystallin in a transgenic mouse model showed altered cyto-
skeletal network, alterations in mitochondrial-sarcomere architecture,
leading to a reduction in the maximal rate of oxygen consumption, al-
terations in the permeability and compromised innermembrane poten-
tial, ultimately triggering apoptotic pathways, cardiomyocyte death,
dilation, and heart failure [165]. Adenovirus-mediated transfection of
cardiomyocytes with R120GαB-crystallin expression resulted in altered
contractile mechanics [165]. While expression of wild type αB-
crystallin leads to decreased aggregation of myopathy-causing desmin
mutant in HEK cells, a double transgenic mouse model expressing
both the myopathy-causing desmin mutant and R120GαB-crystallin
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heart failure before 7 weeks [166].
R120GαB-crystallin expression leads to formation of aggresomes
with high amyloid oligomers and is proposed to be the primary toxic
species affecting the viability of cardiomyocytes [167]. The levels of
aggresome (containing R120GαB-crystallin) did not correlate with dis-
ease, as blocking aggresome formation led to increased levels of toxic
amyloid oligomer and decreased cardiomyocyte viability [168]. Expres-
sion of Hsp22 or Hsp25 could prevent the formation of R120GαB-
crystallin amyloid oligomers [169]. While wild-type αB-crystallin has
a beneﬁcial role in the formation of desmin ﬁlament networks,
R120GαB-crystallin promotes desmin ﬁlament aggregation due to its
increased binding to desmin [137,170]. Proteosomal inhibition and al-
tered autophagy have also been seen upon expression of R120GαB-Fig. 4. Hyperphosphorylation and partitioning into insoluble inclusions of myopathy causing m
dicated myopathy causing mutants of αB-crystallin shown by Simon et al. [174]. Fluorescence
crystallin (achieved by adenovirus mediated transfection). Images of cells without (a–e) and w
myopathy-causingmutants ofαB-crystallin (Myc or His-tagged) in to the indicated sub-cellula
partitioning of themutants to the cytoskeleton fraction. (C) Increased levels of phosphorylation
compared to the wild type in COS cells shown by Simon et al. [174] by Western blotting ana
expressed in transgenic mice probed by Western blotting using phosphor-speciﬁc antibodi
R120GαB-crystallin expressed upon stably transfected in C2C12mouse myoblast cells which is
oratory (Adhikari et al. [97]) by Western blot analysis using S59P-speciﬁc antibodies. (F) Incr
(HspB5) upon expressing in HeLa cells which is further augmented upon oxidative stress induc
ciﬁc antibodies. The ﬁgure also shows the phosphorylation of another sHsp, Hsp27 (HspB1) (
forms perinuclear inclusionswhen expressed in HeLa cells as shown by den Engelsman et al. [1
of the wild type αB-crystallin (S19D/S45D/S59D) which is not prominently seen in the case o
shown in panels D and G are adapted from den Engelsman et al. [140]; the research [174,140
Biochemistry andMolecular Biology. Figure shown in panel E is adapted from Adhikari et al. [9
from Simon et al. [175] (open access material). Note: the panel-labels inside the ﬁgures (as cocrystallin in cells [171,172]. While all these studies highlight the domi-
nant negative role of R120GαB-crystallin, the role of phosphorylation
of the mutant protein has not been speciﬁcally addressed. However,
there are a few studies suggesting the importance of the phosphoryla-
tion of the mutant protein in its intracellular aggregate/inclusion
formation.
Fig. 4 shows examples of hyperphosphorylation of R120GαB-
crystallin partitioning into insoluble inclusions demonstrated by several
earlier studies. ComparativeWestern blot analysis of protein extracts of
the hearts of wild type and R120GαB-crystallin transgenicmice showed
hyperphosphorylation of R120GαB-crystallin at all three S19, S45 and
S59 residues [140]. The inclusions formed upon expressing R120GαB-
crystallin in HeLa cells also showed strong staining against anti-S45P
and S59P αB-crystallin antibodies [140]. Phosphorylation of αB-utants of αB-crystallin from the literature. (A) Formation of intracellular inclusions of in-
images of neonatal cardiomyocytes cells expressing CFP-tagged indicated mutants of αB-
ith protein aggregates (f–h) are shown. (B) Partitioning of the wild type and the indicated
r fraction of COS cells shown by Simon et al., [174] byWestern-blotting. Note the increased
(at S19, S45 and S59) of the expressedMyc/His taggedmutantαB-crystallin (as indicated)
lysis using phospho-speciﬁc antibodies. (D) Hyperphosphorylation of R120Gα-crystallin
es shown by den Engelsman et al. [140]. (E) Hyperphosphorylation (probed at S59) of
negatively modulated by treatingwith the cytokine, TNFα shown by a study from our lab-
eased phosphorylation of R120G mutant compared to the wild type (WT) αB-crystallin
ed bymenadione shown by Simon et al. [175] byWestern blot using various phospho-spe-
G) Phosphorylation-mimicking mutant of R120GαB-crystallin, R120G/S19D/S45D/S59D,
40]. The ﬁgure also shows intra nuclear staining of the phosphorylationmimickingmutant
f R120Gmutant. Figures shown in panels A–C are adapted from Simon et al. [174]; ﬁgure
] were originally published in the Journal Biological Chemistry© the American Society for
7] with permission from Elsevier (through RightsLink). Figure shown in panel F is adapted
mponent) reproduced from the original articles which are not referred to here.
Fig. 5. Phosphorylation-mimicking mutations in R120GαB-crystallin promote aggregation.
The mutations were introduced in the cDNA clone of R120GαB-crystallin by site-directed
mutagenesis. (A) The expression of the protein (S19D/S45D/S59D-R120GαB-crystallin
(3D-R120GαB-crystallin)) in E. coli (BL21 DE3) was induced by 1 mM IPTG and samples
were withdrawn at the indicated time points and analyzed for soluble and insoluble fraction
by SDS-PAGE. The ﬁgure shows the Coomassie brilliant blue stained gel, indicating that
expressed3D-R120GαB-crystallinpartitionspredominantly in the insoluble inclusionbodies.
M represents a sample of puriﬁedαB-crystallin used asmarker. (B) Temperature-dependent
turbidity (measured as optical density at 360 nm) of the 0.2mg/ml protein sample in 20mM
sodium phosphate buffer (pH 7.2) containing 100 mM NaCl. 3D-R120GαB-crystallin (red
line); wild type αB-crystallin (green line), R120GαB-crystallin (violet line) and the phos-
phorylation mimic ofαB-crystallin, 3D-αB-crystallin (orange line). Turbidity measurements
were performed using a Shimadzu UV–Vis−2600 spectrophotometer equipped with a
Peltier (model S-1700) temperature controller. A temperature ramp of 2 °C/min was used.
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with the survival motor neuron (SMN) protein, which is affected in the
case of the R120G αB-crystallin [140].
Expression of themyoﬁbrillarmyopathy causingmutants R120GαB-
crystallin and othermutants (with truncated C-terminal region, Q151X,
and 464delCT [173]) in COS-7 cells showed hyperphosphorylation at all
the three serine residues [174]). Intracellular inclusions of all the three
mutantswere found in some cells, and subcellular fractionation analysis
indicates partitioning of the mutant proteins into cytoskeleton [174].
Thus, the hyperphosphorylation-tendency is not just restricted to
R120GαB-crystallin but also seems to occur with other mutants of αB-
crystallin.
R120GαB-crystallin is phosphorylated at S19, S45 and S59 at higher
level than the wild type αB-crystallin when expressed in HeLa cells
[175]. The level of phosphorylated R120GαB-crystallin further in-
creased upon oxidative stress induced by treating with menadione
[175]. Upon oxidative stress, both thewild type and themutant proteins
partition into insoluble fractions [175]. A study from our laboratory also
showed that the mouse C2C12 myoblasts stably expressing R120GαB-
crystallin showed high phosphorylation (as probed at S59) [97]. Inter-
estingly, treating the cells with TNFα led to decrease in the observed
phosphorylation levels of the mutant protein [97]; the reason for such
decrease in the phosphorylation is not yet understood. Thus, based on
the above described studies, it is reasonable to conclude that
R120GαB-crystallin is inherently hyperphosphorylated regardless of
cell type, and external agents couldmodulate its hyperphosphorylation.
Other mutants (Q151X, and 464delCT) also seem to get
hyperphosphorylated and form insoluble intracellular aggregates
[174]. However, the reason for suchhyperphosphorylation is not under-
stood and needs further investigations. The possibilities include: (i) the
mutant proteins trigger stress responsewhich leads to sustained activa-
tion of p38MAP kinase pathway, and/or (ii) the mutation-induced con-
formational change, and changes in the oligomeric assembly/
distribution make them susceptible/amenable for phosphorylation.
The interaction of phosphorylated wild typeαB-crystallinwith SMN
protein leads to nuclear import of the protein [140]. Though
hyperphosphorylated R120GαB-crystallin strongly interacts with
SMN, both the SMN protein and phosphorylated R120GαB-crystallin
colocalize in the cytoplasmic and perinuclear aggregates [140]. It was
also observed that R120GαB-crystallin and desmin also colocalize in
the intracellular inclusions [163,164]. The formation of insoluble inclu-
sions may be due to increased afﬁnity of the mutant protein for its tar-
gets and formation of insoluble complexes leading to co-aggregation.
Increased aggregation propensity ofmutant proteinmay also contribute
to formation of insoluble inclusions. We are currently investigating
these aspects. Fig. 5A shows that the pseudo phosphorylation mutant
of R120GαB-crystallin forms inclusion bodies upon expressing it in
Escherichia coli. It is to be noted that wild type αB-crystallin, the phos-
phorylation mimic of αB-crystallin and R120GαB-crystallin are
expressed in soluble forms in E. coli as reported earlier [59,176]. When
the puriﬁed inclusion body of 3D-R120GαB-crystallin was dissolved in
6 M urea and subjected to refolding, it yielded a clear solution which
was further puriﬁed to homogeneity by gel-ﬁltration and ion-
exchange chromatography. In order to investigate its thermal stability,
we have performed temperature-dependent turbidity measurement
as optical density at 360 nm of a 0.2 mg/ml sample of 3D-R120GαB-
crystallin in sodium phosphate buffer and compared it with those of
the wild type αB-crystallin, 3D-αB-crystallin and R120GαB-crystallin
(Fig. 5B). Interestingly, the turbidity of the sample of 3D-R120GαB-
crystallin sharply increases at around 45 °C and reaches maximum at
~55 °C and then decreases with further increase in temperature. The
sharp fall of turbidity value at higher temperature is due to ﬂocculation
and consequent removal of the aggregated sample from the optical
path. Wild typeαB-crystallin shows a relatively minor gradual increase
in turbidity value beyond65 °Cwhich further increases above 80 °C. 3D-
αB-crystallin shows a relatively sharp increase in turbidity value above62 °C. Surprisingly, R120GαB-crystallin shows increase in turbidity only
above 85 °C. From these results it is evident that phosphorylation-
mimicking mutations have general tendency to destabilize either wild
type or the R120G αB-crystallin. However, the extent of destabilization
effect in the case of 3D-R120GαB-crystallin is the highest. Further de-
tailed study on these aspects of aggregation propensities, effect of
mixed oligomer or hetero-oligomer formation and interactionwith des-
min are currently underway. Our ﬁnding presented here indicates that
phosphorylation increases the aggregation propensity of R120GαB-
crystallin which, at least in part, is involved in the molecular basis of
pathological manifestation in the cardiomyopathy-causing mutation.10. Conclusions and perspectives
It is emerging from several studies from different laboratories that
(i) aging and various stresses lead to accumulation/increased phosphor-
ylation of αB-crystallin in several tissues such as eye lens, retina, heart
and skeletalmuscle, (ii) phosphorylatedαB-crystallin partitions into in-
soluble fractions (cytoskeleton) and (iii) phosphorylation of αB-
crystallin has dual role that manifests both in beneﬁcial and deleterious
outcomes depending on the extent and duration of stress and phos-
phorylation; initial stage (reversible) seems to be beneﬁcial while ad-
vanced stage (irreversible) is deleterious. Though complete
understanding on the subject of role of phosphorylation of αB-
crystallin in its function needs further investigations with respect to
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ous outcome depending on the extent of phosphorylation and/or stress
seems to be supported by various studies from different laboratories as
discussed in the review.
Only a fraction ofαB-crystallin is phosphorylated in vivo, depending
on the various stimuli or stress or their duration. For example only 10%
ofαB-crystallin is phosphorylated in cells exposed to heat and NaCl and
15–20% in cells treated with reagents such as arsenite, PMA,
anisomycin, H2O2, and sorbitol [39]. Ischemic preconditioning in rat
heart increases phosphorylation of αB-crystallin ~27% [156]. We can
presumewith conﬁdence that mixed oligomers of phosphorylated sub-
units of αB-crystallin exist with unphosphorylated subunits and/or as
hetero-oligomers with the subunits of other sHsps in vivo due to dy-
namic subunit exchange process as well as possible phosphorylation
of a few subunits of the existing oligomers. Therefore, understanding
the structural and functional aspects of the mixed oligomer forms
(with varying degree of phosphorylation) is important. An earlier
study from our laboratory has shown that the phosphorylation mimic,
3DαB-crystallin exhibits enhanced rate of subunit exchange [59]. Im-
portantly, our earlier study [59] as well as a recent study from another
laboratory [61] show that mixed oligomer formation could in fact mod-
ulate the resultant chaperone activity, indicating that the degree of
phosphorylation would have functional inﬂuence on the oligomeric
species of αB-crystallin. However, the ﬁner details of structural and
functional outcome of mixed oligomer formation are not completely
understood. Dominant effects of R120GαB-crystallin on oligomeric
size distribution and phosphorylation levels of Hsp27 have been dem-
onstrated in HeLa cells [175]. Phosphorylation may have destabilizing
effects, the extent of destabilization varying with the degree of phos-
phorylation in the mixed oligomers. As discussed earlier, phosphor-
ylation may modulate the “dynamic partitioning”, giving rise to
apparent discriminative effects. The extent of such modulation
depends of the extent of phosphorylation in the mixed oligomeric
species.Fig. 6. Schematic representation of “Dynamic Partitioning” of αB-crystallin to one of its targets
reactive oxygen species, proteosomal inhibition or drugs) and chronic or acute inﬂammation le
phosphorylation ofαB-crystallin. Thus, phosphorylatedαB-crystallin accumulates with aging, s
could also lead to the depletion of unphosphorylated subunits in the soluble fractions due to t
depending on the degree of accumulation of phosphorylated subunits.The dynamics of cytoskeleton are crucial for cell survival [159–161].
Given the knowledge from the literature that phosphorylated αB-
crystallin increasingly binds to or partitions into the cytoskeleton, the
interaction would be critical for cytoskeleton stability and dynamics,
and therefore for cell survival (schematically illustrated in Fig. 6).
The cytoskeleton is a highly dynamic network of protein ﬁlaments
that spans through the cytosol of eukaryotic cells [161]. Actin ﬁlaments
andmicrotubuli provide structure, points of attachments and are deter-
minants of the shape of cells. They are important for intracellular trans-
port, cell movement and cell adhesion [161]. They are also important for
mitochondrial organization and function in the cells [177,178]. There-
fore, a critical balance of stabilization and dynamics of cytoskeleton is
important for cell survival and cellular functions. For example, antican-
cer drugs have been developed that either destabilize or over stabilize
the microtubules triggering cell-death and are in use clinically [179].
Therefore, lower degree of phosphorylation of αB-crystallin and hence
its interactionwith cytoskeletonmay be necessary for optimal stabiliza-
tion and the protective outcome, while too much stabilization of cyto-
skeleton by excessively phosphorylated αB-crystallin might disturb
the cytoskeleton dynamics and trigger deleterious consequences. In ad-
dition, excessive partitioning to the cytoskeleton (or nucleoskeleton)
would also deplete both the unphosphorylated and phosphorylated
subunits (due to mixed oligomer formation) in the soluble fractions,
thereby preventing its interactions with other targets (for example
those involved in apoptotic pathways). Thus, phosphorylation of αB-
crystallin may have dual role in eliciting either beneﬁcial or deleterious
outcomes depending on the extent of phosphorylation and its increased
interaction with cytoskeleton. While involvement of other conditional,
cellular context-dependentmechanism(s) for the dual role is also possi-
ble, it is still to be understood. As mentioned earlier, reports of phos-
phorylation of αB-crystallin both increasing and decreasing its anti-
apoptotic activity are known. Therefore, understanding the relation be-
tween extent of phosphorylation, mixed-oligomer formation, relative
partitioning/interactions of phosphorylated αB-crystallin/mixed, the cytoskeleton, depending on the extent of phosphorylation. Stresses (caused by heat,
ad to sustained activation of pathways (especially p38 MAPK), which result in progressive
tresses or diseases and partitions into insoluble fractions (cytoskeletal). This phenomenon
heir existence as mixed oligomers in vivo, resulting in beneﬁcial or deleterious outcomes,
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pathway is important. It is possible that the populations of αB-
crystallin species available for interactions with factors of apoptotic
pathwayswould still exist at the low levels of phosphorylation. Howev-
er, hyperphosphorylation leads to increased partitioning of phosphory-
lated/mixed oligomers of αB-crystallin to the cytoskeleton and hence
depletion of αB-crystallin species available for interactions with factors
of apoptotic pathways and hence decreased anti-apoptotic activity. Mu-
tations (e.g., R120G) inαB-crystallin also lead to hyperphosphorylation
and formation of insoluble inclusions. Thus, all the abovementioned as-
pects lead us to propose “good-in-moderation and bad-in-excess”
hypothesis for phosphorylation of αB-crystallin.
As discussed earlier, hyperphosphorylation of mutants of αB-
crystallinwhich is involved in some cardiomyopathies has beendemon-
strated. Various mechanisms proposed for the basis of desmin-related
cardiomyopathy caused by the R120Gmutation inαB-crystallin include
(i) altered conformation and oligomeric size with decreased chaperone
property [176,180], (ii) improper interactions between themutant pro-
tein and desmin [137,163,164] and intermediate ﬁlaments affecting
mitochondria-sarcomere architecture [165], (iii) formation of cytotoxic
amyloid oligomers [167] and (iv) proteosomal inhibition and modula-
tion of autophagy [171,172]. Though which is the primary cause and
which are consequences is debatable, interfering with these improper
associations and aggregation seems to have better outcome. For exam-
ple geranylgeranylacetone-induced expression of Hsp22 or Hsp25 and
cardiac-speciﬁc expression of Hsp22 in transgenic R120αB-crystallin
mice resulted in decreased amyloid oligomer and aggregates, improved
cardiac function and survival [181]. Disrupting the interactions of
R120GαB-crystallin with Hsp27 by a peptide aptamer has been shown
to abolish the dominant negative effect of the mutant protein [182]. In-
terestingly, exercise in the transgenicmicewith cardiac-speciﬁc expres-
sion of R120GαB-crystallin improves the survival (100%, while all
unexercised mice had died) [183]. The pre-amyloid oligomer level
was found to be decreased by 47% compared with the unexercised
mice [183]. Other independent studies have shown that exercise can in-
crease the levels of heat shock proteins including sHsps (see review
[184,185]). Exercise might also decrease phosphorylation of sHsps
since about ~60% decrease in the oxidative stress-induced phosphoryla-
tion (at Thr180 &Tyr182) of p38 MAPK (activation) is shown in
exercised rats [186].
Considering the inherent hyperphosphorylation of the mutant pro-
tein, independent of the cell type in which it is expressed (see Fig. 4),
it is likely that phosphorylation is a key aspect in several observations
madewithmutation-associated pathology. Therefore, inhibition or low-
ering the extent of phosphorylation should have therapeutic potential.
p38 MAP kinase pathway and p44 kinase pathways are obvious targets
moderating phosphorylation. As S45 phosphorylation ofαB-crystallin is
mostly involved in cell cycle and S59 phosphorylation seems to be
prominent under stress conditions, targeting one of the prominent
stress- or inﬂammation-related kinase pathways, i.e., p38 MAP kinase
pathway could be a choice for moderation of the phosphorylation of
αB-crystallin. So far there seems to be no inhibitor known for
MAPKAP kinase-2 (substrate of the p38 MAPK) which phosphorylates
αB-crystallin (and Hsp27). However, inhibition of either p38 MAPK or
its activation (upstream to p38MAPK) would be useful. Inhibitors of
p38 MAPK have been developed to target the kinase for some human
diseases such as arthritis, cancer involving inﬂammation [187,188].
Transient/temporary inhibition of p38 MAP kinase pathway could be
preferred as low level of phosphorylation of αB-crystallin would have
protective effects. This also minimizes deleterious consequences, if
any, of completely inhibiting the kinase. Experimental veriﬁcation of
this possibility would be very useful for developing strategies for man-
aging several pathological conditions involving the role of αB-
crystallin or other sHsps. Thus, we conclude that phosphorylation of
αB-crystallin seems to have both beneﬁcial and deleterious outcomes
depending on the extent of phosphorylation. Moderation ofhyperphosphorylation of αB-crystallin and/or its disease-causing mu-
tants might form one of the future strategies for disease-management.
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